drugset / Trial / NCT04950660

Oral Caffeine Use for Pain Management in AIS Patients After Spinal Fusion

NCT04950660

Phase 4 Completed 61 enrolled Children's Mercy Hospital Kansas City
RandomizedParallel-groupTriple-blindSupportive care

Summary

Prospective, randomized control trial To determine if oral caffeine decreases the frequency of opioid demand in children with adolescent idiopathic scoliosis after their spinal fusion surgery To compare pain scale ratings, number of requests for diazepam, average heart rate, average blood pressure, sex, age, ethnicity, post-op day of discharge, operative time, estimated intraoperative blood loss, remittance post-surgery, length of hospital stay, and segments fused during spinal fusion surgery.

Timeline

Start
2019-12-11
Primary completion
2024-01-20
Completion
2024-08-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Caffeine Small molecule 100 mg